Xilio Therapeutics, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Xilio Therapeutics, Inc. (XLO) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$3.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-03-23
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2024-12-31 was -$5.00K.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2023-12-31 was $0.00.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2023-09-30 was -$1.00K.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-12-31 was $0.00.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was -$3.00K.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$3.00K.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$1.00K.
- Xilio Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$19.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month as first filed | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$3.00K 10-K · filed 2026-03-23 | |||
| 2024-09-30 | $2.00K 10-Q · filed 2025-11-13 | -$2.00K 10-Q · filed 2024-11-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$1.00K derived: sum of 2 quarters · filed 2025-03-11 | -$3.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.00K 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$2.00K 10-Q · filed 2024-08-08 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.00K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$1.00K 10-Q · filed 2023-11-09 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | -$19.00K 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$19.00K 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$19.00K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |